Poseida Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Poseida Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 50% to $64,703,000. Profit margin reached -191%. Total operating expenses were $194,207,000.
Profit Margin
| 2017 | 2.98M | -19.66M | -658.69% |
|---|---|---|---|
| 2018 | 0 | -44.40M | |
| 2019 | 0 | -92.63M | |
| 2020 | 0 | 2.45M | |
| 2021 | 31.23K | 4.40M | 14097.81% |
| 2022 | 130.36M | -64.00M | -49.1% |
| 2023 | 64.70M | -123.43M | -190.76% |
PSTX Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 64.70M | 130.36M | 31.23K | 0 | 0 | 0 | 2.98M |
Cost of revenue | 156.77M | 5.17M | 4.55M | 2.58M | 1.19M | 0 | 0 |
Gross profit | -92.06M | 125.18M | -4.52M | -2.58M | -1.19M | 0 | 2.98M |
Operating exp. | |||||||
Research and development | 156.77M | 152.89M | 136.73K | 103.52K | 60.39M | 30.88M | 19.09M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 194.20M | 190.43M | 172.64K | 126.54K | 78.85M | 40.55M | 24.57M |
Operating income | -129.50M | -59.94M | -141.41K | -126.54K | -85.53M | -41.98M | -19.66M |
Other income (expenses), net | 6.18M | -3.51M | 16.43K | -129.64M | -994K | -2.25M | 1.40M |
Income before tax | -123.32M | -63.45M | -124.97K | -129.77K | -86.52M | -44.60M | -20.18M |
Income tax expense | 107K | 544K | -4.52M | -2.58M | 6.11M | -202K | -527K |
Net income | -123.43M | -64.00M | 4.40M | 2.45M | -92.63M | -44.40M | -19.66M |
Earnings per share | |||||||
Basic EPS | -1.37 | -0.89 | 0.07 | 0.06 | -2.33 | -1.24 | -0.49 |
Diluted EPS | -1.37 | -0.89 | 0.07 | 0.06 | -2.33 | -1.24 | -0.49 |
| Data source | Data source | Data source | Data source |